Warning: Invalid argument supplied for foreach() in /home/urs/public_html/hafeli_lab/publications.php on line 39

To check out the content of a publication, please click on the bolded title.

Publications Books Book Chapters Patents Dissertations



  1. Buchwalder C, Rodriguez-Rodriguez C, Schaffer P, Karagiozov S, Saatchi K, Häfeli UO (2017). A New Tetrapodal 3-Hydroxy-4-Pyridinone Ligand for Complexation of Zirconium-89 for Positron Emission Tomography (PET) Imaging. Dalton Trans 46, 9654-9663
  2. Bokharaei M, Saatchi K, Häfeli UO (2017). A Single Microfluidic Chip with Dual Surface Properties for Protein Drug Delivery. Int J Pharm 521, 84-91
  3. Esquinas P, Uribe C, Gonzales M, Rodriguez-Rodriguez C, Häfeli UO, Celler A (2017). Accuracy of Rhenium-188 SPECT/CT activity quantification for applications in radionuclide therapy using clinical reconstruction methods. Physics in Medicine & Biology 62, 6379-6396
  4. Schmitt V, Szeitz A, Klassen TL, Häfeli UO (2017). An Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Vancomycin Requiring Only 2 µL of Rabbit Serum. American Journal of Analytical Chemistry 8, 553-563
  5. Saatchi K, Tod SE, Leung D, Nicholson KE, Andreu I, Buchwalder C, Schmitt V, Häfeli UO, Gray S (2017). Characterization of Alendronic- and Undecylenic Acid Coated Magnetic Nanoparticles for the Targeted Delivery of Rosiglitazone to Subcutaneous Adipose Tissue. Nanotechnol Biol Med 13(2) 559-568
  6. Auyeung A, Casillas-Santana MA, Martinez-Castanon GA, Slavin YN, Zhao W, Asnis J, Häfeli UO, Bach H (2017). Effective control of molds using a combination of nanoparticles. PLOS One 12(1): e0169940
  7. Schneider T, Löwa A, Karagiozov S, Sprenger L, Gutierrez L, Esposito T, Marten GU, Saatchi K, Häfeli UO (2017). Facile Microwave Synthesis of Uniform Magnetic Nanoparticles with Minimal Sample Processing. J Magn Mag Mat 421, 283-291
  8. Dutz S, Hayden ME, Häfeli UO (2017). Fractionation of magnetic microspheres in a microfluidic spiral: Interplay between magnetic and hydrodynamic forces. PLOS One 12(1): e0169919
  9. Le TN, Straatman L, Yanai A, Garnis C, Häfeli UO, Westerberg BD, Gregory-Evans K (2017). Magnetic stem cell targeting to the inner ear. J Magn Mag Mat 443, 385-396
  10. Slavin YN, Asnis J, Häfeli UO, Bach H (2017). Metal nanoparticles: understanding the mechanisms behind antibacterial activity. Journal of Nanobiotechnology, in press
  11. Esquinas P, Rodriguez-Rodriguez C, de la Vega J, Bokharaei M, Saatchi K, Shirmohammad M, Häfeli UO, Sossi V, Celler A (2017). Re-188 image performance assessment using small animal multi-pinhole SPECT/PET/CT system. Physica Medica 33(1) 26-37
  12. 2016

  13. Bokharaei M, Schneider T, Dutz S, Stone R, Mefford OT, Häfeli UO (2016). 3D Simulation of Droplet Formation and Production of Monodispersed Magnetic Polymeric Microspheres in a Microfluidic Chip. Microfluidics and Nanofluidics 20, 1-14
  14. Gong T, Wang Z, Zhang Y, Zhang Y, Yan Y, Liu Y, Liu X, Wang Y, Yang X, Zhao L, Hou M, Zhang H, Ruse ND, Troczynski T, Häfeli UO (2016). A comprehensive study of osteogenic calcium phosphate silicate cement: material characterization and in vitro/in vivo testing. Advanced Healthcare Materials 5, 457-466
  15. Ranamukhaarachchi SA, Lehnert S, Ranamukhaarachchi SL, Sprenger L, Schneider T, Mansoor I, Rai K, Häfeli UO, Stoeber B (2016). A Micromechanical Comparison of Human and Porcine Skin Before and After Preservation by Freezing. Scientific reports 6:32074
  16. Esquinas P, Tanguay JF, Gonzalez M, Vuckovic M, Rodriguez-Rodriguez C, Häfeli UO, Celler A (2016). Accuracy, Reproducibility and Uncertainty Analysis of Thyroid Probe-Based Activity Measurements for Determination of Dose Calibrator Settings. Med Phys 43 (12) 6309-6321
  17. Ranamukhaarachchi SA, Schneider T, Lehnert S, Sprenger L, Campbell J, Mansoor I, Lai J, Rai K, Dutz J, Häfeli UO, Stoeber B (2016). Development and Validation of an Artificial Mechanical Skin Model for the Study of Interactions between Skin and Microneedles. Macromolecular Materials and Engineering 301, 306-314
  18. Ranamukhaarachchi SA, Padeste C, Dübner M, Häfeli UO, Stoeber B, Cadarso VJ (2016). Integrated hollow microneedle-optofluidic biosensor for therapeutic drug monitoring in sub-nanoliter volumes. Scientific reports 6:29075
  19. Baker JHE, McPhee KC, Moosvi FS, Saatchi K, Häfeli UO, Minchinton AI, Reinsberg SA (2016). Multi-modal magnetic resonance imaging and histology of vascular function in xenografts using macromolecular contrast agent Hyperbranched Polyglycerol (HPG-GdF). Contrast Media & Molecular Imaging 11, 77-88
  20. Gong T, Chen Y, Zhang Y, Zhang Y, Liu X, Troczynski T, Häfeli UO (2016). Osteogenic and anti-osteoporotic effects of risedronate-added calcium phosphate silicate cement. Biomedical Materials 11 (4) 045002
  21. 2015

  22. Mansoor I, Lai J, Ranamukhaarachchi S, Schmitt V, Lambert D, Dutz JP, Häfeli UO, Stoeber B (2015). A microneedle-based method for the characterization of diffusion in skin tissue using doxorubicin as a model drug. Biomed Microdev 17, 61
  23. Zhong Y, Leung V, Wan LY, Dutz S, Ko FK, Häfeli UO (2015). Electrospun magnetic nanofibre mats - a new bondable biomaterial using remotely activated magnetic heating. J Magn Mag Mat 380, 330-334
  24. Sprenger L, Dutz S, Schneider T, Odenbach S, Häfeli UO (2015). Simulation and experimental determination of the online separation of blood components with the help of microfluidic cascading spirals. Biomicrofluidics 9, 044110
  25. de la Vega J, Häfeli UO (2015). Utilization of Nanoparticles as X-Ray Contrast Agents for Diagnostic Imaging Applications. Contrast Media & Molecular Imaging 10, 81-95
  26. 2014

  27. Kiang TK, Häfeli UO, Ensom MHH (2014). A Comprehensive Review on the Pharmacokinetics of Antibiotics in Interstitial Fluid Spaces in Humans: Implications on Dosing and Clinical Pharmacokinetic Monitoring. Clin Pharmacokinet 53 (8), 695-730
  28. Gong T, Wang Z, Zhang Y, Sun C, Yang Q, Troczynski T, Häfeli UO (2014). Preparation, characterization, release kinetics, and in vitro cytotoxicity of calcium silicate cement as a risedronate delivery system. J Biomed Mater Res Part A 102A (7) 2295-2304
  29. 2013

  30. Mansoor I, Liu Y, Häfeli UO, Stoeber B (2013). Arrays of hollow out-of-plane microneedles made by metal electrodeposition onto solvent cast conductive polymer structures. Journal of Micromechanics and Microengineering 23, 085011
  31. Bleul R, Thiermann R, Marten GU, House MJ, Pierre TG, Häfeli UO, Maskos M (2013). Continuously manufactured magnetic polymersomes - a versatile tool (not only) for targeted cancer therapy. Nanoscale 5, 11385-11393
  32. Bashar AE, Metcalfe A, Yanai A, Laver C, Häfeli UO, Gregory-Evans CY, Moritz OL, Matsubara JA, Gregory-Evans K (2013). Influence of iron oxide nanoparticles on innate and genetically modified secretion profiles of mesenchymal stem cells. IEEE Transactions on Magnetics 49, 389-393
  33. Bleul R, Thiermann R, Saatchi K, Häfeli UO, Maskos M (2013). Multifunctional nanocarriers for biomedical applications. Proc of SPIE 8595, 1N-9
  34. de la Vega J, Elischer P, Schneider T, Häfeli UO (2013). Uniform microspheres: Definition of monodispersity, methods of formation and applications. Nanomedicine 8, 265-285
  35. 2012

  36. Dutz S, Hayden ME, Schaap A, Stoeber B, Häfeli UO (2012). A microfluidic spiral for size-dependent fractionation of magnetic microspheres. Journal of Magnetism and Magnetic Materials 324, 3791-3798
  37. Laurent S, Burtea C, Thirifays C, Häfeli UO, Mahmoudi M (2012). Crucial ignored parameters on nanotoxicology: the importance of toxicity assay modifications. PloS ONE 7, e29997
  38. Misri R, Meier D, Yung A, Kozlowski P, Saatchi K, Häfeli UO (2012). Development and evaluation of dual-modality (MRI/SPECT) molecular imaging bioprobe. Nanomed Nanotechnol Biol Med 8, 1007-1016
  39. Yanai A, Häfeli UO, Metcalfe A, Soema P, Addo L, Gregory-Evans CY, Po K, Shan XH, Moritz O, Gregory-Evans K (2012). Focused magnetic stem cell targeting to the retina using superparamagnetic iron oxide nanoparticles. Cell Transplantation 21, 1137-1148
  40. Mansoor I, Häfeli UO, Stoeber B (2012). Hollow out-of-plane polymer microneedles made by solvent casting for transdermal drug delivery. J MEMS 21, 44-52
  41. Saatchi K, Soema P, Gelder N, Misri R, McPhee K, Baker J, Reinsberg SA, Brooks DE, Häfeli UO (2012). Hyperbranched polyglycerols as trimodal imaging agents: design, biocompatibility and tumor uptake. Bioconjugate Chemistry 23, 372-381
  42. Saatchi K, Gelder N, Gershkovich P, Sivak O, Wasan KM, Kainthan RK, Brooks DE, Häfeli UO (2012). Long-circulating nontoxic cardiac blood pool imaging agent based on hyperbranched polyglycerols. International Journal of Pharmaceutics 422, 418-427
  43. Misri R, Saatchi K, Häfeli UO (2012). Nanoprobes for hybrid SPECT/MR molecular imaging. Nanomedicine: Nanotechnology, Biology and Medicine 7, 719-733
  44. Kiang TK, Schmitt V, Ensom MH, Chua B, Häfeli UO (2012). Therapeutic drug monitoring in interstitial fluid: a feasibility study using a comprehensive panel of drugs. Journal of Pharmaceutical Sciences 101, 4642-4652
  45. 2011

  46. Burrill J, Häfeli UO, Liu DM (2011). Advances in radioembolization - Embolics and radioisotopes. Journal of Nuclear Medicine and Radiation Therapy 2, 1000107
  47. Mansoor I, Häfeli UO, Stoeber B (2011). Arrays of solvent cast hollow out-of-plane microneedles for drug delivery. In: IEEE MEMS 2011, Cancun, Mexico, 1027-1030
  48. Häfeli UO, Ensom MH, Kiang TK, Stoeber B, Chua B, Pudek M, Schmitt V (2011). Comparison of vancomycin concentrations in blood and interstitial fluid: a possible model for less invasive therapeutic drug monitoring. Clinical Chemistry and Laboratory Medicine 49, 2123-2125
  49. Schneider T, Chapman GH, Häfeli UO (2011). Effects of chemical and physical parameters in the generation of microspheres by hydrodynamic flow focusing. Colloids and Surfaces B: Biointerfaces 87, 361-368
  50. Misri R, Saatchi K, Ng SSW, Kumar U, Häfeli UO (2011). Evaluation of 111In labeled antibodies for SPECT imaging of mesothelin. Nucl Med Biol 38, 885-896
  51. Laurent S, Dutz S, Häfeli UO, Mahmoudi M (2011). Magnetic fluid hyperthermia: Focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci 166, 8-23
  52. Boros E, Lin Y-HS, Ferreira CL, Patrick BO, Häfeli UO, Adam MJ, Orvig C (2011). One to chelate them all: Towards a versatile, all-encompassing bifunctional chelator for 64Cu, 99mTc, 186/188Re, 55Co. Dalton Trans 40, 6253-6259
  53. Misri R, Saatchi K, Häfeli UO (2011). Radiolabeling of fab and f(ab)2 antibody fragments with 99mTc(I) tricarbonyl core using a new bifunctional tridentate ligand. Nucl Med Commun 32, 324-329
  54. 2010

  55. Mahmoudi M, Simchi A, Imani M, Shokrgozar M, Milani A, Häfeli UO, Stroeve P (2010). A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. Colloids and Surfaces B: Biointerfaces 75, 300-309
  56. Häfeli UO, Saatchi K, Elischer P, Misri R, Bokharaei M, Labiris NR, Stoeber B (2010). Lung perfusion imaging with monosized biodegradable microspheres. Biomacromolecules 11, 561-567
  57. Schmitt V, Rodrigues B, Häfeli UO, Saatchi K (2010). Study of the binding capacity of heparin functionalized magnetic microparticles for cardiac lipoprotein lipase and their preliminary evaluation ex vivo in rat hearts. AIP Conf Proc 1311, 408-415
  58. Dengler M, Saatchi K, Dailey JP, Matsubara J, Mikelberg FS, Häfeli UO, Yeung SN (2010). Targeted delivery of magnetic cobalt nanoparticles to the eye following systemic administration. AIP Conf Proc 1311, 329-336
  59. 2009

  60. Häfeli UO, Riffle JS, Harris LA, Carmichael AY, Mark F, Dailey JP, Bardenstein D (2009). Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol Pharmaceutics 6, 1417-1428
  61. Boros E, Häfeli UO, Patrick BO, Adam MJ, Orvig C (2009). Design, synthesis and imaging of small amphiphilic rhenium and 99mTechnetium tricarbonyl complexes. Bioconjugate Chemistry 20, 1002-1009
  62. Song KY, Chiao M, Stoeber B, Häfeli U, Gupta MM, Zhang WJ (2009). Formation of uniform microspheres using a perforated silicon membrane: a preliminary study. Journal of Medical Devices 3, 034503
  63. Bowen ML, Lim NC, Ewart CB, Misri R, Ferreira CL, Häfeli UO, Adam MJ, Orvig C (2009). Glucosamine conjugates bearing N,N,O-donors: Potential imaging agents utilizing the [M(CO)3] core (M = Re, Tc). Dalton Trans 42, 9216-9227
  64. Häfeli UO, Mokhtari A, Liepmann D, Stoeber B (2009). In vivo evaluation of a microneedle-based miniature syringe for intradermal drug delivery. Biomedical Microdevices 11, 943-950
  65. Bowen ML, Chen ZF, Roos AM, Misri R, Häfeli UO, Adam MJ, Orvig C (2009). Long-chain rhenium and technetium glucosamine conjugates. Dalton Trans 42, 9228-9236
  66. Tokoro H, Nakabayashi T, Fujii S, Zhao H, Häfeli UO (2009). Magnetic particles with high magnetization useful for immunoassay. J Magn Magn Mater 321, 1676-1678
  67. Mahmoudi M, Shokrgozar M, Simchi A, Imani M, Milani A, Stroeve P, Vali H, Häfeli UO, Sasanpour P, Bonakdar S (2009). Multiphysics flow modeling and in vitro toxicity of iron oxide nanoparticles coated with polyvinyl alcohol. J Phys Chem C 113, 2322 - 2331
  68. Zhao H, Saatchi K, Häfeli UO (2009). Preparation of biodegradable magnetic microspheres with poly(lactic acid) coated magnetite. J Magn Magn Mater 321, 1356-1363
  69. Saatchi K, Häfeli UO (2009). Radiolabeling of biodegradable polymeric microspheres with [99mTc(CO)3] and in vivo evaluation using microSPECT/CT imaging. Bioconjug Chem 20, 1209-1217
  70. Mahmoudi M, Simchi A, Imani M, Häfeli UO (2009). Superparamagnetic iron oxide nanoparticles with rigid cross-linked polyethylene glycol fumarate coating for application in imaging and drug delivery. J Phys Chem C 113, 8124-8131
  71. 2008

  72. Saatchi K, Häfeli UO (2008). Magnetic Carriers Conference 2008. NanoMedicine 3, 415-421
  73. Schneider T, Zhao H, Jackson JK, Chapman GH, Dykes J, Hafeli UO (2008). Use of hydrodynamic flow focusing for the generation of biodegradable camptothecin-loaded polymer microspheres. J Pharm Sci 97, 4943-4954
  74. 2007

  75. Häfeli UO, Unnithan J, Pauer GJ, Prayson RA (2007). Fibrin glue system for adjuvant brachytherapy of brain tumors with 188 Re- and 186 Re-labeled microspheres. Eur J Pharm Biopharm 65, 282-288
  76. Saatchi K, Häfeli UO (2007). One-pot syntheses, coordination and characterization of application-specific biodegradable ligand-polymers. Dalton Trans 39, 4439-4445
  77. Zhao H, Gagnon J, Häfeli UO (2007). Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres. Biomagn Res Technol 5:2
  78. Häfeli UO, Gilmour K, Zhou A, Lee S, Hayden ME (2007). Simulation and implementation of magnetic bandages for drug targeting: Button magnets versus Halbach arrays. Journal of Magnetism and Magnetic Materials 311, 323 - 329
  79. 2006

  80. Hayden ME, Häfeli UO (2006). 'Magnetic bandages' for targeted delivery of therapeutic agents. Journal of Physics and Condensed Matter 18, S2877-S2891
  81. 2005

  82. Zhang H, Häfeli UO (2005). Experimentation and modeling of electrodeposition of Rhenium-188 on medical 316L stainless steel wires. Plating and Surface Finishing 92, 40 - 44
  83. Häfeli UO, Lobedann MA, Steingroewer J, Moore, Riffle JS (2005). Optical method for measurement of magnetophoretic mobility of individual magnetic microspheres in defined magnetic field. J Magn Magn Mater 293, 224 - 239
  84. Yu JF, Häfeli UO, Xiao J, Li S, Dong M, Yin D, Wang Y (2005). Radiolabeling of poly(histidine)-derivatized biodegradable microspheres with rhenium-188 tricarbonyl complex [188Re(CO)3(H2O)3]. Nucl Med Commun 26, 453 - 458
  85. Algur E, Macklis RM, Häfeli UO (2005). Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate cancer and myeloma cell lines. Int J Radiat Oncol Biol Phys 61, 535-542
  86. 2004

  87. Häfeli UO, Zhang H, Bahrehmand F, Reynaert N (2004). Development of an automated electroplater and dosimetry system for the electrodeposition and quality control of radioactive stents. Applied Radiation & Isotopes 61, 1313-1321
  88. Häfeli UO (2004). Magnetically modulated therapeutic systems. International Journal of Pharmaceutics 277, 19-24
  89. Iacob G, Rotariu O, Strachan NJC, Häfeli UO (2004). Magnetizable needles and wires - modeling an efficient way to target magnetic microspheres in vivo. Biorheology 41, 599-612
  90. Zhang H, Häfeli UO (2004). Preparation and characterization of radioactive Co/188Re stents intended for lung cancer treatment using an electrodeposition method. Journal of Medical Engineering Technology 28, 197-204
  91. Cao J, Wang Y, Yu J, Xia J, Zhang C, Yin D, Häfeli UO (2004). Preparation and radiolabeling of surface-modified magnetic nanoparticles with rhenium-188 for magnetic targeted radiotherapy. Journal of Magnetism and Magnetic Materials 277, 165-174
  92. Häfeli UO, Subbarayan M, Mukhtar H (2004). Response to Letters to the Editor: Cooking Annexin V: A simple 1-pot procedure to destroy its phosphatidylserine-binding activity. Journal of Nuclear Medicine 45, 1098-1099
  93. Gupta S, Adhami VM, Subbarayan M, MacLennan GT, Lewin JS, Häfeli UO, Fu P, Mukhtar H (2004). Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Cancer Research 64 3334-3343
  94. 2003

  95. Yu J, Sands MJ, Dong Y, Häfeli UO (2003). 90Y-oxine-ethiodol, a potential radiopharmaceutical for the treatment of liver cancer. Applied Radiation & Isotopes 58, 567-573
  96. Subbarayan M, Häfeli UO, Feyes DK, Unnithan J, Emancipator SN, Mukhtar H (2003). A simplified method for the preparation of 99mTc-annexin V and its biological evaluation for in vivo imaging of apoptosis after photodynamic therapy. Journal of Nuclear Medicine 44, 650-656
  97. Kaminski MD, Nunez L, Ghebremeskel AN, Eastman JA, Chang F, Chien TH, Kasza KE, Fischer PF, Rosengart AJ, McDonald L, Xie Y, Johns L, Pytel P, Häfeli UO (2003). Magnetically responsive microparticles for targeted drug and radionuclide delivery. A review of recent progress and future challenges. Argonne, IL: Argonne National Laboratory ANL-03/28, 1-92
  98. Häfeli UO, Yu J, Farudi F, Li Y, Tapolsky G (2003). Radiolabeling of magnetic targeted carriers (MTC) with indium-111. Nuclear Medicine & Biology 30, 761-769
  99. 2002

  100. Häfeli UO, Ciocan R, Dailey JP (2002). Characterization of magnetic particles and microspheres and their magnetophoretic mobility using a digital microscopy method. European Cells and Materials 3 Suppl. 2, 24-27
  101. Yu JF, Häfeli UO, Dong Y, Sands MJ, Li YH, Failing S, Leakakos T, Tapolsky G (2002). Radiolabeling of magnetic targeted carriers with several therapeutic and imaging radioisotopes. Eur. Cells Mat., 3 Suppl. 2 16-18
  102. Reynaert N, Häfeli UO (2002). Response to Dr. Janicki's letter to the editor [Med. Phys. 29, 260 (2002)]. Medical Physics 29, 261
  103. 2001

  104. Häfeli UO, Pauer GJ, Miller DD (2001). Feasibility study for the treatment of metastatic prostate cancer with the radioactive antiandrogen I-125-bicalutamide (I-125 Casodex). Journal of Labelled Compounds and Radiopharmaceuticals 44, S670-S672
  105. Rudershausen S, Häfeli UO, Grüttner C, Teller J (2001). Novel chelator containing particles specific for controlled radioisotope delivery. Journal of Labelled Compounds and Radiopharmaceuticals 44, S838-S840
  106. Häfeli U, Pauer G, Failing S, Tapolsky G (2001). Radiolabeling of magnetic particles with rhenium-188 for cancer therapy. Journal of Magnetism and Magnetic Materials 225, 73-78
  107. Reynaert N, Häfeli U (2001). Self-absorption correction for P-32, Au-198 and Re-188 stents: Dose point kernel calculations versus Monte Carlo. Medical Physics 28, 1883-1898
  108. Häfeli UO, Roberts WK, Pauer GJ, Kraeft SK, Macklis RM (2001). Stability of biodegradable radioactive rhenium (Re-186 and Re-188) microspheres after neutron-activation. Applied Radiation and Isotopes 54, 869-879
  109. 2000

  110. Evans EE, Häfeli UO, Wusirika R, Morrison PW (2000). Diamond like carbon coatings for rhenium wires and foils. Amorphous and nanostructured carbon 593, 433-438
  111. Häfeli UO, Roberts WK, Meier DS, Ciezki JP, Pauer GJ, Lee EJ, Weinhous M (2000). Dosimetry of a W-188/Re-188 beta line source for endovascular brachytherapy. Medical Physics 27, 668-675
  112. Erzurum VZ, Häfeli UO, Hirko MK, Schmidt SP, Rubin JR (2000). Local application of beta-particle radiation to reduce venous anastomotic intimal hyperplasia in polytetrafluorethylene arteriovenous fistulas. Vascular Surgery 34, 377-383
  113. 1999

  114. Schütt W, Grüttner C, Teller J, Westphal F, Häfeli UO, Paulke B, Goetz P, Finck W (1999). Biocompatible magnetic polymer carriers for in vivo radionuclide delivery. Artificial Organs 23, 98-103
  115. Häfeli UO, Casillas S, Dietz DW, Pauer GJ, Rybicki LA, Conzone SD, Day DE (1999). Hepatic tumor radioembolization in a rat model using radioactive rhenium (186Re/188Re) glass microspheres. International Journal of Radiation Oncology Biology Physics 44, 189-199
  116. Häfeli UO, Pauer GJ (1999). In vitro and in vivo toxicity of magnetic microspheres. Journal of Magnetism and Magnetic Materials 194, 76-82
  117. Roberts WK, Häfeli UO (1999). Modeling rhenium-186 and rhenium-188 distribution in a neutron-activated rhenium wire and effect of the distribution on beta dosimetry in a water phantom. Applied Radiation and Isotopes 51, 543-549
  118. Ciezki JP, Häfeli UO, Song P, Urankar-Nagy N, Ratliff NB, Rybicki L, Brill K, Meier D (1999). Parenchymal cell proliferation in coronary arteries after PTCA: A human tissue bank study. International Journal of Radiation Oncology Biology Physics 45, 963-968
  119. Häfeli UO, Lee EJ, Ciezki J, Pauer GJ, Weinhous MS (1999). Suitability of beta-emitting rhenium for inhibiting restenosis in coronary arteries. Journal of Brachytherapy International 15, 1-11
  120. 1998

  121. Häfeli UO, Warburton MC, Landau U (1998). Electrodeposition of radioactive rhenium onto stents to prevent restenosis. Biomaterials 19, 925-933
  122. Conzone SD, Häfeli UO, Day DE, Ehrhardt GJ (1998). Preparation and properties of radioactive rhenium glass microspheres intended for in-vivo radioembolization therapy. Journal of Biomedical Materials Research 42, 617-625
  123. 1997

  124. Schütt W, Grüttner C, Häfeli UO, Zborowski M, Teller J, Putzar H, Schümichen C (1997). Applications of magnetic targeting in diagnosis and therapy - possibilities and limitations. A mini-review. Hybridoma 16, 109-117
  125. Gallo JM, Häfeli U (1997). Correspondence re: A.S. Lübbe et al., Preclinical experiences with magnetic drug targeting. Cancer Research 57, 3063-3064
  126. 1995

  127. Häfeli UO, Sweeney SM, Beresford BA, Humm JL, Macklis RM (1995). Effective targeting of magnetic radioactive Y-90-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results. Nuclear Medicine and Biology - International Journal of Radiation Applications and Instrumentation Part B 22, 147-155
  128. Häfeli UO, Pauer GJ, Macklis RM (1995). Treatment of mouse tumors with radioactive magnetic microspheres: Model for intracavitary radiotherapy. Proceedings of the International Symposium on Controlled Release of Bioactive Materials 22, 89-90
  129. 1994

  130. Häfeli UO, Sweeney SM, Beresford BS, Sim EH, Macklis RM (1994). Magnetically directed poly(lactic acid) Y-90-microspheres: Novel agents for targeted intracavitary radiotherapy. Journal of Biomedical Materials Research 28, 901-908
  131. 1992

  132. Häfeli U, Atcher RW, Morris CE, Beresford B, Humm JL, Macklis RM (1992). Polymeric radiopharmaceutical delivery systems. Radioactivity & Radiochemistry 3, 11-14
  133. 1991

  134. Häfeli UO, Tiefenauer LX, Schubiger PA, Weder HG (1991). A lipophilic complex with Re-186/Re-186 incorporated in liposomes suitable for radiotherapy. Nuclear Medicine and Biology - International Journal of Radiation Applications and Instrumentation Part B 18, 449-454


Book Chapters


Last Modified: December 05, 2012.
Back to Top